Grants per year
Personal profile
Research Interests
Daniel Batlle MD is the Earle, del Greco, Levin Professor of Medicine at Northwestern University. He has been a Professor of Medicine at Northwestern and past Division Chief for 18 years . His clinical and research interests include acid-base disturbances, electrolyte disorders, hypertension, and diabetic nephropathy. Bench research currently involves the study of the renin angiotensin system and enzymes that degrade angiotensin 2 such as ACE2 and its potential therapeutic use.
Certifications and Licenses
| Internal Medicine | |
| Nephrology |
Training Experience
| 1976 | Internship, Saint John Hospital and Medical Center, Detroit, Michigan |
| 1977 | Residency, Wayne State University |
| 1979 | Fellowship, Univ. of Illinois Hospital |
Education/Academic qualification
MD, University of Barcelona
… → 1973
Research interests
- Hypertension
- Kidney
- Nephrology
Fingerprint Dive into the research topics where Daniel Batlle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 18 Similar Profiles
Kidney
Medicine & Life Sciences
Renal Tubular Acidosis
Medicine & Life Sciences
Angiotensin II
Medicine & Life Sciences
Diabetic Nephropathies
Medicine & Life Sciences
Acidosis
Medicine & Life Sciences
Chronic Renal Insufficiency
Medicine & Life Sciences
Potassium
Medicine & Life Sciences
Hypertension
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2004 2023
The Role of MicroRNAs in Corneal Epithelial Homeostasis
Batlle, D., Lavker, R. M., Peng, H. & Thaxton, C. S.
Kennedy Institute - National Eye Clinic
7/1/19 → 7/31/23
Project: Research project
MicroRNAs
Homeostasis
Corneal Epithelium
HDL Lipoproteins
Nanoparticles
Prot #16244: A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Event-Driven Phase III Study to Investigate the Efficacy and Safety of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects
Batlle, D., Molitch, M. E. & Wallia, A.
Bayer HealthCare Pharmaceuticals, Inc.
1/5/16 → 5/31/20
Project: Research project
Urinary Renin Angiotensin System in Diabetes
Batlle, D., Molitch, M. E., Rademaker, A. W. & Wysocki, J.
National Institute of Diabetes, Digestive and Kidney Diseases
6/15/15 → 4/30/20
Project: Research project
Renin-Angiotensin System
Renin
Diabetes Complications
Type 1 Diabetes Mellitus
Albuminuria
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
Batlle, D., Molitch, M. E. & Wallia, A.
Joslin Diabetes Center, Inc., National Institute of Diabetes, Digestive and Kidney Diseases
9/15/17 → 6/30/19
Project: Research project
Telecommunications
Allopurinol
Multicenter Studies
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Clinical Trials
Prot #BAY 94-8862/16243: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY-94-8862 in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropa
Batlle, D., Molitch, M. E. & Wallia, A.
Bayer HealthCare Pharmaceuticals, Inc.
1/2/14 → 1/2/17
Project: Research project
Research Output 1978 2020
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent
Serfozo, P., Wysocki, J., Gulua, G., Schulze, A., Ye, M., Liu, P., Jin, J., Bader, M., Myöhänen, T., García-Horsman, J. A. & Batlle, D., Jan 1 2020, In : Hypertension (Dallas, Tex. : 1979). 75, 1, p. 173-182 10 p.Research output: Contribution to journal › Article
Angiotensin II
lysosomal Pro-X carboxypeptidase
Kidney
Lung
angiotensin I (1-7)
Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?
Marquez, A. & Batlle, D., Oct 1 2019, In : Kidney international. 96, 4, p. 815-817 3 p.Research output: Contribution to journal › Comment/debate
Lisinopril
Diabetic Nephropathies
Angiotensin-Converting Enzyme Inhibitors
Peptides
angiotensin I (1-7)
Progressive Hypertension and Severe Left Ventricular Outflow Tract Obstruction
Cameron, A. C., Lang, N. N., Dominiczak, A. F., Jennings, G. L. R., Batlle, D., Bursztyn, M., Chugh, A. R., Floras, J. S., Taler, S. J., Touyz, R. M. & Delles, C., Dec 1 2019, In : Hypertension (Dallas, Tex. : 1979). 74, 6, p. 1216-1225 10 p.Research output: Contribution to journal › Article
Ventricular Outflow Obstruction
Hypertension
Proximal renal tubular acidosis with and without fanconi syndrome
Kashoor, I. & Batlle, D., Sep 2019, In : Kidney Research and Clinical Practice. 38, 3, p. 267-281 15 p.Research output: Contribution to journal › Review article
Open Access
Fanconi Syndrome
Renal Tubular Acidosis
Bicarbonates
Sodium-Phosphate Cotransporter Proteins
Cystinosis
1
Citation
(Scopus)
Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus
For the Diabetes Control, Complications Trial (DCCT)/Epidemiology of Diabetes Interventions, Complications (EDIC) Study, Oct 1 2019, In : Physiological reports. 7, 19, e14242.Research output: Contribution to journal › Article
Open Access
Angiotensinogen
Type 1 Diabetes Mellitus
Chronic Renal Insufficiency
Diabetes Complications
Kidney